CARDIOVASCULAR SYSTEM INJURIES IN PATIENTS WITH COVID-19. Review
Article PDF (Українська)

Keywords

COVID-19, SARS-CoV-2, pandemic, cardiovascular diseases, myocardial damage

Abstract views: 99
PDF Downloads: 54

How to Cite

Moskalyuk , V., Randiuk, Y., Syrota , B., & Balanyuk , I. (2022). CARDIOVASCULAR SYSTEM INJURIES IN PATIENTS WITH COVID-19. Review. Medical Science of Ukraine (MSU), 18(2), 45-54. https://doi.org/10.32345/2664-4738.2.2022.07

Abstract

Relevance. The outbreak of new coronavirus disease (COVID-19) caused by SARS-CoV-2 is the biggest medical problem of the 21st century.

Every year, humanity is faced with new diseases of viral etiology, the unpredictable occurrence and severe manifestations of which often lead to the stupor of scientists and physicians around the world. Although the virus primarily affects the lungs, and the clinical manifestations of the disease are dominated by respiratory symptoms, but it significantly affects the risk of development and clinical course of cardiovascular disease. It should be noted that heart disease with COVID-19 can be observed in patients with chronic diseases of the cardiovascular system, as well as in patients who had no signs of heart disease before this infection.

Objective: to consider current data on cardiovascular disease in patients with COVID-19.

Methods. Analysis of latest data presented in PubMed by keywords "COVID-19", "SARS-CoV-2", "pandemic", "cardiovascular disease", "myocardial infarction". Search depth – 2 years (2020-2022), with retrospective deepening of some positions until 2003.

Results. Coronavirus interacts with the cardiovascular system on many levels, increasing the incidence of patients with concomitant cardiovascular disease and provoking myocardial damage and dysfunction. In addition, cardiovascular disease in patients with coronavirus disease may pose an increased risk of mortality. Therefore, an understanding of the damage to SARS-CoV-2 to the cardiovascular system and its underlying mechanisms is of the utmost importance to ensure that the treatment of these patients is timely and effective and that mortality is reduced.

Conclusions. COVID-19, caused by SARS-CoV-2, is a global pandemic that is evolving in real time. Concomitant cardiovascular disease is common in patients on COVID-19, and these patients have a higher risk of morbidity and mortality. Therefore, in addition to routine examinations for coronavirus disease, patients with cardiovascular disease should receive ancillary studies of the heart and blood vessels, such as cardiac biomarkers, cardiac imaging, electrocardiography, echocardiography and angiography.

https://doi.org/10.32345/2664-4738.2.2022.07
Article PDF (Українська)

References

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Mar 17; 323(11):1061-1069. DOI: 10.1001/jama.2020.1585.

View at:

Publisher Site: https://jamanetwork.com/journals/jama/fullarticle/2761044

PubMed: https://pubmed.ncbi.nlm.nih.gov/32031570/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042881/

Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, Yuan Q, Xiao X. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020 Jun; 39(6):1011-1019. DOI: 10.1007%2Fs10096-020-03874-z.

View at:

Publisher Site: https://link.springer.com/article/10.1007/s10096-020-03874-z

PubMed: https://pubmed.ncbi.nlm.nih.gov/32291542/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154215/

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. DOI: 10.1016/S0140-6736(20)30183-5.

View at:

Publisher Site: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/31986264/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159299/

Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, Si H-R, Zhu Y, Li B, Huang C-L, Chen H-D, Chen J, Luo Y, Guo H, Jiang R-D, Liu M-Q, Chen Y, Shen X-R, Wang X, Zheng X-S, Zhao K, Q-J Chen, Deng F, Liu L-L, Yan B, Zhan F-X, Wang Y-Y, Xiao G-F, Shi Z-L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. DOI: 10.1038/s41586-020-2012-7.

View at:

Publisher Site: https://www.nature.com/articles/s41586-020-2012-7

PubMed: https://pubmed.ncbi.nlm.nih.gov/32015507/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095418/

Hendren NS, Drazner MH, Bozkurt B, Cooper Jr LT. Description and proposed

managemen of the acute COVID-19 cardiovascular syndrome. Circulation. 2020 Jun; 141(23):1903-14. DOI: 10.1161/circulationaha.120.047349.

View at:

Publisher Site: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047349

PubMed: https://pubmed.ncbi.nlm.nih.gov/32297796/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314493/

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223):507-513. DOI: 10.1016/S0140-6736(20)30211-7

View at:

Publisher Site: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/32007143/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191275/

Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, Brown TS, Nigoghossian CD, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM, Parikh SA. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardil. 2020 May 12;75(18):2352-2371. DOI: 10.1016/j.jacc.2020.03.031.

View at:

Publisher Site: https://cdnsciencepub.com/doi/10.1139/cjpp-2021-0390

PubMed: https://pubmed.ncbi.nlm.nih.gov/32201335/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198856/

Kreutz R, Algharably E, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer T, Wang J, Burnier M. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. European Society of Hypertension COVID-19 Task Force Review of Evidence. Cardiovasc Res. 2020 Aug 1;116(10):1688-1699. DOI: 10.1093/cvr/cvaa097

View at:

Publisher Site: https://europepmc.org/article/pmc/7184480

PubMed: https://pubmed.ncbi.nlm.nih.gov/32293003/

PubMed Central: https://pubmed.ncbi.nlm.nih.gov/34269396/

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020 Apr 23;382(17):1653-1659. DOI: 10.1056/NEJMsr2005760.

View at:

Publisher Site: https://www.nejm.org/doi/10.1056/NEJMsr2005760

PubMed: https://pubmed.ncbi.nlm.nih.gov/32227760/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121452/

Danser AHJ, Epstein M, Batlle D. Renin-angiotensin system blockers and the COVID-19 oandemic: at present there is no evidence to abandon renin-angiotensin system blockers. Hypertension. 2020 Jun; 75(6):1382-1385. DOI: 10.1161/HYPERTENSIONAHA.120.15082

View at:

Publisher Site: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.120.15082

PubMed: https://pubmed.ncbi.nlm.nih.gov/32208987/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225046/

Kreutz R, Algharably E, Azizi M, Dobrowolski P, Guzik T, Januszewicz A, Persu A, Prejbisz A, Riemer T, Wang J, Burnier M. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19. European Society of Hypertension COVID-19 Task Force Review of Evidence. Cardiovasc Res. 2020 Aug 1;116(10):1688-1699. DOI: 10.1093/cvr/cvaa097

View at:

Publisher Site: https://academic.oup.com/cardiovascres/article/116/10/1688/5819836?login=false

PubMed: https://pubmed.ncbi.nlm.nih.gov/32293003/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184480/

Gallagher S, Jones DA, Anand V, Mohiddin S. Diagnosis and management of patients with acute cardiac symptoms, troponin elevation and culprit-free angiograms. Heart. 2012 Jul; 98(13):974-81. DOI: 10.1136/heartjnl-2011-301121

View at:

Publisher Site: https://heart.bmj.com/content/98/13/974

PubMed: https://pubmed.ncbi.nlm.nih.gov/22581519/

Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 May 5; 133(9):1025-1031. DOI: 0.1097/CM9.0000000000000744.

View at:

Publisher Site: https://journals.lww.com/cmj/Fulltext/2020/05050/Clinical_characteristics_of_novel_coronavirus.4.aspx

PubMed: https://pubmed.ncbi.nlm.nih.gov/32044814/

PubMed Central https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147277/

Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 May-Jun; 63(3):390-391. DOI: 10.1016/j.pcad.2020.03.001.

View at:

Publisher Site: https://www.sciencedirect.com/science/article/pii/S0033062020300554?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/32169400/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127395/

Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May; 17(5):259-260. DOI: 10.1038/s41569-020-0360-5.

View at:

Publisher Site: https://www.nature.com/articles/s41569-020-0360-5

PubMed: https://pubmed.ncbi.nlm.nih.gov/32139904/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095524/

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Jul 1; 5(7):802-810. DOI: 10.1001/ jamacardio.2020.0950.

View at:

Publisher Site: https://jamanetwork.com/journals/jamacardiology/fullarticle/2763524

PubMed: https://pubmed.ncbi.nlm.nih.gov/32211816/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097841/

Walters TE, Kalman JM, Patel SK, Mearns M, Velkoska E, Burrell LM. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. Europace. 2017 Aug 1;19(8):1280-1287. DOI: 10.1093/europace/euw246

View at:

Publisher Site: https://academic.oup.com/europace/article/19/8/1280/2194467

PubMed: https://pubmed.ncbi.nlm.nih.gov/27738071/

Ocaranza MP, Palomera C, Roman M, Bargetto J, Lavandero S, Jalil JE. Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism. Life Sci. 2006 Feb 28; 78(14):1535-42. DOI: 10.1016/j.lfs.2005.07.026

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S0024320505009458?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/16229862/

Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 May; 17(5):259-260. DOI: 10.1038/s41569-020-0360-5.

View at:

Publisher Site: https://www.nature.com/articles/s41569-020-0360-5

PubMed: https://pubmed.ncbi.nlm.nih.gov/32139904/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095524/

Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020 May 1; 116(6):1097-1100. DOI: 10.1093/cvr/cvaa078

View at:

Publisher Site: https://academic.oup.com/cardiovascres/article/116/6/1097/5813131

PubMed: https://pubmed.ncbi.nlm.nih.gov/32227090/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184507/

Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. Hum Pathol. 2003 May; 34(5):497-503. DOI: 10.1016/s0046-8177(03)00078-9

View at:

Publisher Site: https://www.sciencedirect.com/science/article/abs/pii/S0046817703000789?via%3Dihub

PubMed: https://pubmed.ncbi.nlm.nih.gov/12792925/

Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19). ClinicalTrials.gov identifier: NCT04307693.

View at:

Publisher Site: https://clinicaltrials.gov/ct2/show/NCT04307693

Tocilizumab for SARS-CoV2 Severe Pneumonitis. ClinicalTrials.gov identifier: NCT04315480.

View at:

Publisher Site: https://clinicaltrials.gov/ct2/show/results/NCT04315480

Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia Caused by 2019-nCoV (HC-nCoV). ClinicalTrials.gov identifier: NCT04261517.

View at:

Publisher Site: https://clinicaltrials.gov/ct2/show/NCT04261517

Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016 Aug; 49:129-33. DOI: 10.1016/j.ijid.2016.06.015

View at:

Publisher Site: https://www.sciencedirect.com/science/article/pii/S1201971216311006

PubMed: https://pubmed.ncbi.nlm.nih.gov/27352628/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110556/

Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, Wang LF, Gao H, Wang Y, Dong CF, Li Y-J, Xie X-J, Feng C, Liu L. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Infection. 2020 Oct; 48(5):773-777. DOI: 10.1007/s15010-020-01424-5

View at:

Publisher Site: https://www.preprints.org/manuscript/202003.0180/v1

PubMed: https://pubmed.ncbi.nlm.nih.gov/32277408/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146072/

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.